These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 2898510

  • 1. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain.
    Schneider JS, Denaro FJ.
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):452-8. PubMed ID: 2898510
    [Abstract] [Full Text] [Related]

  • 2. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
    Luellen BA, Miller DB, Chisnell AC, Murphy DL, O'Callaghan JP, Andrews AM.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
    [Abstract] [Full Text] [Related]

  • 3. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry.
    Strömberg I, Björklund H, Dahl D, Jonsson G, Sundström E, Olson L.
    Brain Res Bull; 1986 Aug; 17(2):225-36. PubMed ID: 3094835
    [Abstract] [Full Text] [Related]

  • 4. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [Abstract] [Full Text] [Related]

  • 5. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Waters CM, Hunt SP, Jenner P, Marsden CD.
    Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous functional recovery from parkinsonism is not due to reinnervation of the dorsal striatum by residual dopaminergic neurons.
    Rothblat DS, Schneider JS.
    Brain Res Bull; 1994 Dec; 34(3):309-12. PubMed ID: 7914468
    [Abstract] [Full Text] [Related]

  • 7. Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.
    Schneider JS, Yuwiler A, Markham CH.
    Exp Neurol; 1986 Feb; 91(2):293-307. PubMed ID: 3484707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
    Reinhard JF, Miller DB, O'Callaghan JP.
    Neurosci Lett; 1988 Dec 19; 95(1-3):246-51. PubMed ID: 3265770
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
    Zhang J, Sun B, Yang J, Chen Z, Li Z, Zhang N, Li H, Shen L.
    Mol Med Rep; 2022 Mar 19; 25(3):. PubMed ID: 35039876
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion.
    Chadi G, Møller A, Rosén L, Janson AM, Agnati LA, Goldstein M, Ogren SO, Pettersson RF, Fuxe K.
    Exp Brain Res; 1993 Mar 19; 97(1):145-58. PubMed ID: 7907549
    [Abstract] [Full Text] [Related]

  • 16. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 17. The MAP kinase cascade is activated prior to the induction of gliosis in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of dopaminergic neurotoxicity.
    O'Callaghan JP, Martin PM, Mass MJ.
    Ann N Y Acad Sci; 1998 May 30; 844():40-9. PubMed ID: 9668663
    [Abstract] [Full Text] [Related]

  • 18. Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry.
    Schneider JS, Markham CH.
    Brain Res; 1986 May 14; 373(1-2):258-67. PubMed ID: 2872936
    [Abstract] [Full Text] [Related]

  • 19. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA, Rothblat DS, Joyce JN, Schneider JS.
    Synapse; 1995 Jan 14; 19(1):46-55. PubMed ID: 7709343
    [Abstract] [Full Text] [Related]

  • 20. Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
    Kurosaki R, Muramatsu Y, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Metab Brain Dis; 2003 Jun 14; 18(2):139-46. PubMed ID: 12822832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.